Navigation Links
Sosei Announces Update on Phase I Trials for SD118
Date:11/27/2007

TOKYO, November 27 /PRNewswire-FirstCall/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), a biopharmaceutical company, today announces an update on the status of its collaborative project SD118, which is under development for the treatment of neuropathic pain. SD118 has commenced a multiple dose ascending Phase I study and the initial single ascending dose Phase I study to explore higher doses has been extended.

SD118 is being jointly developed with NeuroDiscovery Ltd (ASX Code: NDL) and its wholly owned subsidiary NeuroSolutions Ltd under a Collaboration Agreement concluded in June 2006. SD118 was previously under investigation in Japan for a different indication and now, following re-profiling and evaluation in experimental animal models, has demonstrated its potential as a new oral therapy for neuropathic pain.

The latest study is a double blind, placebo controlled, multiple dose, sequential group, dose escalation trial in healthy male volunteers to assess the safety, tolerability and pharmacokinetic profile of SD118 administered as an oral capsule. The study, involving some 36 subjects in 4 cohorts, is being conducted in a single centre in the UK under a CTA (Clinical Trial Authorisation) regulatory approval.

Additionally, in recognition of the drug's emerging positive safety profile and the successful completion of the original trial protocol, it has been decided to extend the previously announced single dose Phase I study to explore additional higher doses. Regulatory approval has been obtained for this trial extension. A further announcement will be made when the extension phase is completed and all the study results are fully analysed.

Mr Shinichi Tamura, President & CEO of Sosei, said: "I am delighted that clinical development of SD118 continues to make good progress. This project has the potential to provide a valuable addition to currently available therapies in an area of notable unmet medical need."


'/>"/>
SOURCE Sosei Group Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Sosei and Vectura Announce Start of Phase II Studies of QVA149 for the Treatment of COPD
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... ... Mike Day, a former Navy SEAL who was shot 27 times during ... Kona on October 10th. , Mike is running the race to raise awareness and ... cutting-edge treatments that restore their quality of life. More than 300,000 post ...
(Date:9/4/2015)... ... 04, 2015 , ... The conference program for the upcoming ... 9-10, 2015 at the Diplomat Resort & Spa has been announced and is ... at the top of their field and will be presenting sessions such as ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... Benker Residence in South Glastonbury, Connecticut, has been selected for the Residential Award ... significant energy efficiency and resiliency measures. Chosen from a highly competitive field of ...
(Date:9/4/2015)... ... 2015 , ... EMED Jamaica Global Ltd. (EMED), Jamaica’s premier ... into a multi-year agreement with Health City Cayman Islands. , ( http://www.healthcitycaymanislands.com ) ... healthcare, Jamaican healthcare and Health City Cayman Islands to deliver high-quality, affordable healthcare ...
(Date:9/3/2015)... Fullerton, Calif. (PRWEB) , ... September 03, 2015 , ... ... in Fullerton, where innovative medicine is the norm not the exception. , St. Jude ... and the American Heart Association/American Stroke Association, making it one of only 10 hospitals ...
Breaking Medicine News(10 mins):Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3
... of the Department of Pediatrics at the University of ... Rady Children,s Hospital-San Diego has received a $10 million ... and Blood Institute. A world renowned physician-scientist in ... of investigators from UC San Diego and the Sanford-Burnham ...
... Reporter , THURSDAY, Sept. 23 (HealthDay News) -- Distracted driving ... the space of three years, according to new U.S. government ... deaths in car accidents from 2001 to 2007, the researchers ... driving rose 28 percent in just three years, from 4,572 ...
... School of Medicine have found that the costs of care ... five times higher than for patients who remained with hospice. ... use emergency department care and be hospitalized. The results ... of Clinical Oncology. Led by Melissa D.A. Carlson, PhD, ...
... the opposing team,s offensive drive to the end zone, ... events to initiate, or block, different actions or functions. ... Center recently discovered a potential molecular playbook for blocking ... a well-known precursor of heart failure. Researchers uncovered a ...
... Center and GLG Pharma, LLC announced today that they ... Pharma, LLC has acquired the exclusive worldwide rights to ... inhibitors. Researchers at Moffitt discovered several classes of ... anti-cancer drugs. "Persistently activated STAT3 is a ...
... on women,s health over the last two decades has lessened ... to cardiovascular disease, breast cancer, and cervical cancer, says a ... has yielded less but still significant progress in reducing the ... committee that wrote the report. However, ...
Cached Medicine News:Health News:Texting Taking a Deadly Toll on Roads 2Health News:Texting Taking a Deadly Toll on Roads 3Health News:Patients with cancer who stop hospice care boost health-care costs 2Health News:Molecular 'playbook' for halting heart failure risk factor uncovered 2Health News:Increased attention to women's health research has yielded gains on some important conditions, but progress lags on others 2Health News:Increased attention to women's health research has yielded gains on some important conditions, but progress lags on others 3
(Date:9/4/2015)... , September 4, 2015 Future ... Allergic Rhinitis drugs - new ... Where is the market for allergic rhinitis drugs ... Visiongain ,s new report shows you potential revenues ... prospects. Our 326 page report provides 273 ...
(Date:9/4/2015)... Research and Markets ... the "Pharmacovigilance (London, UK - December 7-9, ... Understanding PhV today - the principles and practice ... safety. This course aims to provide ... entrants as well as experienced operators in drug ...
(Date:9/4/2015)... 2015 Research and Markets ( ... Report on China,s Sodium Ibandronate Market, 2010-2019" report to ... clinic under the trade name of Bondronat in ... 1996, sodium ibandronate was approved by the FDA to come ... the trade name of Boniva. However, since drug makers later ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Pharmacovigilance Course: The Principles and Practice of Global PhV for those Working in Drug Safety (London, UK - December 7-9, 2015) 2Investigation Report on China's Sodium Ibandronate Market 2010-2019 2
... Troy Healthcare today announced that the company has purchased ... DRJ Group Inc. Simultaneously, the company unveiled a new gel ... is a subsidiary of Troy Manufacturing Inc., which has manufactured ... manufacturing knowledge and experience with Stopain products, Troy Healthcare will ...
... Calif., Jan. 5, 2011 Cell Biosciences, Inc., ... life science researchers, today announced the launch of ... next-generation imaging products, the FluorChem® M MultiFluor system. ... multicolor fluorescent Western blots with key ease-of-use features ...
Cached Medicine Technology:Troy Healthcare, LLC Acquires Stopain® Brand; Unveils New Pain Relieving Gel Set to Hit Stores in Early 2011 2Cell Biosciences Launches New Platform for Multiplex Western Blot Detection 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: